胸腔镜肺叶切除术与常规开胸治疗肺癌的效果研究  

Study on the efficacy of thoracoscopic lobectomy and conventional thoracotomy for lung cancer

作　　者：曾绍杉[1] 肖首浩 叶树柳 ZENG Shaoshan;XIAO Shouhao;YE Shuiu(Department of Thoracic and Heart Surgery,Sanming First Hospital,Sanming,Fujian,365000,China)

机构地区：[1]三明市第一医院胸心外科,福建三明365000

出　　处：《当代医学》2023年第28期152-154,共3页Contemporary Medicine

摘　　要：目的比较常规开胸治疗和胸腔镜肺叶切除术在肺癌中的应用效果。方法选取2018年1月至2021年6月三明市第一医院收治的78例肺癌患者作为研究对象,随机分为对照组与观察组,每组39例。对照组行常规开胸治疗,观察组行胸腔镜肺叶切除术治疗。比较两组不良术后事件发生率、手术指标及心肺功能。结果观察组不良术后事件发生率为7.69%,低于对照组的25.64%,差异有统计学意义(P<0.05)。观察组术中出血量、引流量均少于对照组,切口长度、留置时间、住院时间均短于对照组,差异有统计学意义(P<0.05)。术后,观察组第1秒用力呼气容积(FEV1)、最大呼气流量(PEF)、用力肺活量(FVC)均大于术前、对照组,6min步行距离(6MWD)长于术前、对照组,且对照组FVC大于术前,6MWD长于术前,差异有统计学意义(P<0.05);对照组手术前后FEV1、PEF比较差异无统计学意义。结论胸腔镜肺叶切除术治疗肺癌的临床效果优于常规开胸治疗,有助于降低患者不良术后事件发生率,优化手术指标,改善患者心肺功能,值得临床推广应用。Objective To compare the efficacy of conventional thoracotomy and thoracoscopic lobectomy in the treatment of lung cancer.Methods 78 patients with lung cancer admitted to the First Hospital of Sanming City from January 2018 to June 2021 were selected as the study sub-jects,and they were randomly divided into the control group and the observation group,with 39 cases in each group.The control group received con-ventional thoracotomy,and the observation group received thoracoscopic lobectomy,the incidence of adverse cardiovascular events,surgical indexes and cardiopulmonary function were compared between the two groups.Results The incidence of adverse cardiovascular events was 7.69%in the observation group,which was lower than 25.64%in the control group,and the difference was statistically significant(P<0.05).The amount of bleeding intraoperative and drainage in the observation group were less than those in the control group,and the length of incision,indwelling time and hospitalization time were shorter than those in the control group,the differences were statistically significant(P<0.05).After operation,the forced expiratory volume in one second(FEV1),peak expiratory flow(PEF)and forced vital capacity(FVC)in the observation group were larger than those before operation and those in the control group,and the 6-minute walking distance(6 MWD)was longer than that before operation and that in the control group,and the FVC in the control group was larger than that before operation,and the 6 MWD was longer than that before opera-tion,the differences were statistically significant(P<0.05);there was no significant difference in FEV1 and PEF before and after operation in the control group.Conclusion The clinical effect of thoracoscopic lobectomy in the treatment of lung cancer is better than that of conventional thoracot-omy,which can help to reduce the incidence of adverse cardiovascular events,optimize surgical indicators and improve the cardiopulmonary function of patients,and is worthy of clinical promotion and applicat

关 键 词：肺癌 常规开胸治疗 胸腔镜肺叶切除术 不良术后事件发生率 心肺功能 

分 类 号：R734.2[医药卫生—肿瘤]